tiprankstipranks
PAVmed Inc (PAVM)
NASDAQ:PAVM

PAVmed (PAVM) Stock Price & Analysis

399 Followers

PAVM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.20 - $0.69
Previous Close$0.31
Volume2.31M
Average Volume (3M)609.11K
Market Cap
$37.44M
Enterprise Value$88.37M
Total Cash (Recent Filing)$26.41M
Total Debt (Recent Filing)$49.91M
Price to Earnings (P/E)-0.4
Beta2.00
Apr 11, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.70
Shares Outstanding120,759,886
10 Day Avg. Volume519,609
30 Day Avg. Volume609,106
Standard Deviation0.24
R-Squared0.04
Alpha-0.00243
Financial Highlights & Ratios
Price to Book (P/B)-0.75
Price to Sales (P/S)99.30
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue58.33
Enterprise Value/Gross Profit-27.30
Enterprise Value/Ebitda-1.08
Forecast
Price Target Upside400.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2


Financials

Annual

Ownership Overview

3.77% Mutual Funds
7.00% Other Institutional Investors
89.23% Public Companies and
Individual Investors

PAVM FAQ

What was PAVmed Inc’s price range in the past 12 months?
PAVmed Inc lowest stock price was $0.20 and its highest was $0.69 in the past 12 months.
    What is PAVmed Inc’s market cap?
    Currently, no data Available
    When is PAVmed Inc’s upcoming earnings report date?
    PAVmed Inc’s upcoming earnings report date is Apr 11, 2024 which is in 127 days.
      How were PAVmed Inc’s earnings last quarter?
      PAVmed Inc released its earnings results on Nov 14, 2023. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.137 by -$0.023.
        Is PAVmed Inc overvalued?
        According to Wall Street analysts PAVmed Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does PAVmed Inc pay dividends?
          PAVmed Inc does not currently pay dividends.
          What is PAVmed Inc’s EPS estimate?
          PAVmed Inc’s EPS estimate is -$0.13.
            How many shares outstanding does PAVmed Inc have?
            PAVmed Inc has 120,759,890 shares outstanding.
              What happened to PAVmed Inc’s price movement after its last earnings report?
              PAVmed Inc reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.137. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of PAVmed Inc?
                Among the largest hedge funds holding PAVmed Inc’s share is Cruiser Capital Advisors, Llc. It holds PAVmed Inc’s shares valued at N/A.

                  ---

                  Company Description

                  PAVmed Inc

                  PAVmed, Inc. is a medical device company, which develops and commercializes a pipeline of medical products. Its product portfolio includes DisappEAR, PORTIO, Caldus, Carpx, NextCath, and NextFlo. The company was founded on June 26, 2014 and is headquartered in New York, NY.

                  ---

                  Top 5 ETFs holding PAVM

                  Name
                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  $652.19K
                  8
                  iShares Core S&P Total U.S. Stock Market ETF
                  $37.80
                  8
                  Up to five ETFs with an Outperform Smart Score that hold PAVM. The ETFs are listed according to market value of PAVM within the ETF

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  InMode
                  NovoCure
                  Seagen
                  Insulet

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis